The Marcus (MCS) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
5 Mar, 2026Business overview and strategy
Operates as a diversified entertainment and hospitality company with theatres and hotels across the U.S., managing 985 screens in 78 locations and 17 hotel properties in 8 states.
Fourth largest U.S. theatre exhibitor and manages over 4,650 hotel rooms, 40+ F&B outlets, and 345,000+ sq. ft. of event space.
Focuses on competitive advantages, experienced operations, history of outperformance, growth potential, strong balance sheet, and shareholder value creation.
Significant real estate ownership, with 62% of theatres and seven hotels owned, reducing lease payments and enhancing free cash flow.
Invested $581 million in assets over the past decade to modernize theatres and hotels.
Financial performance
Fiscal 2025 revenues reached $758.5M, with Adjusted EBITDA of $99.3M and a margin of 13.8%.
Market capitalization as of March 2026 was approximately $538.3M.
Q4 2025 saw revenue, operating income, and Adjusted EBITDA increases, outperforming industry benchmarks.
Hotels & Resorts segment reported a 5% revenue increase and 3.4% Adjusted EBITDA growth in Q4 2025.
Fiscal 2025 benefited from a fiscal calendar change, adding six operating days compared to 2024.
Operational highlights
Theatres feature luxury recliner seating in 86% of company-owned locations and 88% of screens, with 83% offering premium large format screens.
Expanded food and beverage offerings in 69% of theatres, with 26% offering in-theatre dining and 62% full liquor service.
Hotels regularly renovated, with recent major investments in The Lofton Hotel, Grand Geneva Resort, The Pfister Hotel, and Hilton Milwaukee.
Group travel demand remains strong, with 91% of Americans planning to travel in 2026 and RevPAR growth expected to resume.
Latest events from The Marcus
- Both divisions outperformed their industries, with strong revenue growth and a robust 2026 outlook.MCS
Q4 202526 Feb 2026 - Q2 revenue dropped 15%, but hotels outperformed and group bookings surged as theatres rebounded.MCS
Q2 20242 Feb 2026 - Record Q3 revenue, earnings, and industry outperformance with a strengthened capital structure.MCS
Q3 202417 Jan 2026 - Q4 revenue up 16.6% and record hotel results, with strong momentum for 2025 growth.MCS
Q4 202423 Dec 2025 - Shelf registration enables up to $150M in securities offerings and 5M-share secondary sales.MCS
Registration Filing16 Dec 2025 - Annual meeting to vote on directors, incentive plan, executive pay, and auditor ratification.MCS
Proxy Filing2 Dec 2025 - Virtual annual meeting to vote on directors, incentive plan, pay, and auditor ratification.MCS
Proxy Filing2 Dec 2025 - Q1 revenue up 7.4%, but net loss widened to $16.8M; strong outlook for films and hotels.MCS
Q1 202519 Nov 2025 - Q2 2025 revenue up 17%, profit returns, theatres lead growth, CapEx to decline post-2025.MCS
Q2 202516 Nov 2025